Tacton Launches Connect to Anything, Powered by Workato, Simplifying Integration for Manufacturers
21.1.2025 15:06:00 CET | Business Wire | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and leading SaaS platform simplifying sales and configuration processes for manufacturers of complex products, today announced the launch of its Connect to Anything integration capability, powered by Workato, the leading enterprise orchestration platform. This innovative solution transforms how manufacturers integrate Tacton CPQ into their digital ecosystems, enabling seamless connections to over 600 enterprise applications, including CRM, ERP, PLM, PIM, and analytics tools.
Manufacturers often face costly inefficiencies from data silos and integration roadblocks as IT teams struggle to keep pace with complex connections. The stakes are high: poor data quality costs organizations an average of $12.9 million annually, according to Gartner’s® 2020 Magic Quadrant™ for Data Quality Solutions. Connect to Anything solves this challenge by making it simple to connect data across applications without heavy reliance on IT. With pre-built connectors, reusable recipes, and a no-code approach, Tacton empowers manufacturers to eliminate silos, streamline workflows, and accelerate their digital transformation journey.
“As manufacturers embrace digital transformation, seamless integration across systems has become mission-critical,” saidJesper Alfredsson, Chief Product Officer, Tacton. “Connect to Anything simplifies this process by enabling manufacturers to unify their digital ecosystems, reduce IT dependency, and achieve faster, smarter operations that drive tangible business outcomes.”
With Connect to Anything, manufacturers can:
- Simplify Integration: Seamlessly connect Tacton CPQ to essential systems with pre-built connectors and no-code recipes.
- Accelerate ROI: Achieve faster implementation and operational efficiency with reduced dependency on IT.
- Maximize CPQ Value: Unlock greater returns from CPQ investments with integration capabilities available from the start of implementation.
Connect to Anything brings together unmatched innovation through this partnership. Tacton has been recognized as a Leader in the Gartner® Magic Quadrant™ for CPQ Applications, while Workato is a Leader in the Gartner® Magic Quadrant™ for Integration Platform as a Service (iPaaS). Together, these industry leaders deliver a powerful solution that helps manufacturers simplify integrations, optimize workflows, and scale operations seamlessly.
“We are thrilled to partner with Tacton, providing manufacturers with seamless integration capabilities that accelerate their journey towards smart factories,” said Nam Le, General Manager of Workato’s Embed Business. “This collaboration exemplifies how leaders in their respective industries can drive powerful outcomes for manufacturers. By embedding Workato’s no-code platform into Tacton CPQ, manufacturers gain unmatched flexibility and efficiency in connecting and optimizing their digital ecosystems. Together, we’re empowering manufacturers to build connected, agile operations that deliver real business value.”
Connect to Anything is available now for manufacturers looking to simplify and accelerate their digital transformation. To learn more about our integration capabilities, visit our website.
About Tacton
Tacton is a leading SaaS company redefining how manufacturers of complex products engage with their buyers. Its cutting-edge buyer engagement platform empowers manufacturers to streamline the buyer journey, deliver personalized, customer-centric experiences, and bring complex products to market faster and more efficiently.
Recognized as a Leader in Gartner’s® Magic Quadrant™ for CPQ Applications, Tacton partners with manufacturers to drive smart factory initiatives and align operations with customer needs. With over 25 years of experience and trusted by more than 100 global leaders like ABB, Daimler, MAN, Scania, Siemens, Xylem, and Yaskawa, Tacton is co-headquartered in Chicago and Stockholm, with regional offices in Karlsruhe, Warsaw, and Tokyo. Learn more at www.tacton.com.
About Workato
Workato transforms technology complexity into business opportunity. As the leader in enterprise orchestration, Workato helps businesses globally streamline operations by connecting data, processes, applications, and experiences. Its AI-powered platform enables teams to navigate complex workflows in real time, driving efficiency and agility. Trusted by a community of 400,000 global users, Workato empowers organizations of every size to unlock new value and lead in today’s fast-changing world. Learn how Workato helps businesses of all sizes achieve more at www.workato.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250116707013/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom